Covea Finance Abbott Laboratories Transaction History

Covea Finance

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 16, 2024	SELL	$100.73 - $112.44 $24.2 Million - $27 Million	-240,451 Reduced 69.49%	105,554 $11 Million
Q1 2024 Apr 19, 2024	SELL	$109.52 - $120.96 $9.01 Million - $9.96 Million	-82,300 Reduced 19.22%	346,005 $39.3 Million
Q4 2023 Jan 08, 2024	SELL	$90.19 - $110.4 $2.85 Million - $3.49 Million	-31,600 Reduced 6.87%	428,305 $47.1 Million
Q3 2023 Oct 10, 2023	BUY	$95.53 - $114.62 $26.2 Million - $31.5 Million	274,700 Added 148.32%	459,905 $44.5 Million
Q2 2023 Jul 07, 2023	SELL	$100.78 - $112.29 $3.94 Million - $4.39 Million	-39,096 Reduced 17.43%	185,205 $20.2 Million
Q1 2023 Apr 17, 2023	SELL	$96.86 - $114.01 $18.4 Million - $21.7 Million	-190,447 Reduced 45.92%	224,301 $22.7 Million
Q4 2022 Feb 02, 2023	BUY	$95.06 - $111.52 $10.6 Million - $12.5 Million	111,900 Added 36.95%	414,748 $45.5 Million
Q3 2022 Oct 27, 2022	BUY	$96.76 - $112.03 $29.3 Million - $33.9 Million	302,848 New	302,848 $29.3 Million

3,217

1.3B

8.74M

8.08M

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $226B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

Get notified when there are updates to the investment portfolio of Covea Finance, based on Form 13F filings with the SEC.

Stay updated on Covea Finance with notifications on news.